AriaNova Bio is a biotechnology R&D company developing research-stage therapeutics across multiple biomedical applications. Current programs include King Skin and Queen Skin, with additional therapeutic programs planned as our pipeline expands.
AriaNova Bio is advancing research-stage therapeutic programs, with current work focused on wound care and inflammatory skin conditions.
Wound-Care Research
King Skin
Research-stage topical formulation
Inflammatory Skin Research
Queen Skin
Research-stage topical formulation
Support Our Research
Help Advance the Next Generation of Therapeutics
AriaNova Bio welcomes research grants, donations, and other forms of financial support to advance laboratory evaluation, preclinical research, and the development of innovative therapeutic formulations.